| 1 |
Du L, Du S, Li J, Wang H. Design, synthesis, and biological evaluation of dual-target COX-2/5-LOX inhibitors for the treatment of inflammation. Med Chem Res 2022. [DOI: 10.1007/s00044-022-02995-8] [Reference Citation Analysis]
|
| 2 |
Alshammari NAH, Bakhotmah DA. Synthesis, reactivity, antimicrobial, and anti-biofilm evaluation of fluorinated 4-amino-3-mercapto-1,2,4-triazin-5(4H)-one and their derivatives. Phosphorus, Sulfur, and Silicon and the Related Elements 2022. [DOI: 10.1080/10426507.2022.2150856] [Reference Citation Analysis]
|
| 3 |
Muthuboopathi G, Rajendran T, Shanawaz S, Moorthi D, Thirunavukkarasu J, Nandhini N, Saminathan V. Research Critique of Thiazolidine Analogues. AJRC 2022. [DOI: 10.52711/0974-4150.2022.00063] [Reference Citation Analysis]
|
| 4 |
Du L, Du S, li J, Wang H. Design, synthesis and biological evaluation of novel 2- (indole arylamide) benzoic acid analogs as dual COX-2 / 5-LOX inhibitors.. [DOI: 10.21203/rs.3.rs-2004218/v1] [Reference Citation Analysis]
|
| 5 |
Vandyshev DY, Shikhaliev KS. Recyclization of Maleimides by Binucleophiles as a General Approach for Building Hydrogenated Heterocyclic Systems. Molecules 2022;27:5268. [DOI: 10.3390/molecules27165268] [Reference Citation Analysis]
|
| 6 |
Oyeka EE, Babahan I, Eboma B, Ifeanyieze KJ, Okpareke OC, Coban EP, Özmen A, Coban B, Aksel M, Özdemir N, Groutso T, Ayogu JI, Yildiz U, Dinçer Bilgin M, Halil Biyik H, Schrage BR, Ziegler CJ, Asegbeloyin JN. Biologically active acylthioureas and their Ni(II) and Cu(II) Complexes: Structural, spectroscopic, anti-proliferative, nucleolytic and antimicrobial studies. Inorganica Chimica Acta 2021;528:120590. [DOI: 10.1016/j.ica.2021.120590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Elzahhar PA, Alaaeddine RA, Nassra R, Ismail A, Labib HF, Temraz MG, Belal ASF, El-Yazbi AF. Challenging inflammatory process at molecular, cellular and in vivo levels via some new pyrazolyl thiazolones. J Enzyme Inhib Med Chem 2021;36:669-84. [PMID: 33618602 DOI: 10.1080/14756366.2021.1887169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 8 |
Sava A, Buron F, Routier S, Panainte A, Bibire N, Profire L. New nitric oxide-releasing indomethacin derivatives with 1,3-thiazolidine-4-one scaffold: Design, synthesis, in silico and in vitro studies. Biomed Pharmacother 2021;139:111678. [PMID: 33964802 DOI: 10.1016/j.biopha.2021.111678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Constantin SM, Lupascu FG, Apotrosoaei M, Focsa AV, Vasincu IM, Confederat LG, Dimitriu G, Lupusoru CE, Routier S, Buron F, Profire L. Antidiabetic effects and safety profile of chitosan delivery systems loaded with new xanthine-thiazolidine-4-one derivatives: in vivo studies. Journal of Drug Delivery Science and Technology 2020;60:102091. [DOI: 10.1016/j.jddst.2020.102091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 10 |
Bhat MA, Al-Omar MA, Naglah AM, Khan AA. Synthesis of Novel Sulfamethaoxazole 4-Thiazolidinone Hybrids and Their Biological Evaluation. Molecules 2020;25:E3570. [PMID: 32781534 DOI: 10.3390/molecules25163570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 11 |
Kerru N, Gummidi L, Bhaskaruni SVHS, Maddila SN, Jonnalagadda SB. Ultrasound-assisted synthesis and antibacterial activity of novel 1,3,4-thiadiazole-1H-pyrazol-4-yl-thiazolidin-4-one derivatives. Monatsh Chem 2020;151:981-90. [DOI: 10.1007/s00706-020-02625-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Abumelha HMA, Saeed A. Synthesis of some 5‐arylidene‐2‐(4‐acetamidophenylimino)‐thiazolidin‐4‐one derivatives and exploring their breast anticancer activity. J Heterocycl Chem 2020;57:1816-1824. [DOI: 10.1002/jhet.3906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Jin Q, Chen H, Chen W, Fu Z, Guan L, Jiang H. Synthesis and biological effects of naphthalene-chalcone derivatives. Med Chem Res 2020;29:877-86. [DOI: 10.1007/s00044-020-02525-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Nithyabalaji R, Krishnan H, Subha J, Sribalan R. Synthesis, molecular structure, in vitro and in silico studies of 4-phenylmorpholine-heterocyclic amides. Journal of Molecular Structure 2020;1204:127563. [DOI: 10.1016/j.molstruc.2019.127563] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
das Neves AM, Berwaldt GA, Avila CT, Goulart TB, Moreira BC, Ferreira TP, Soares MSP, Pedra NS, Spohr L, dE Souza AAA, Spanevello RM, Cunico W. Synthesis of thiazolidin-4-ones and thiazinan-4-ones from 1-(2-aminoethyl)pyrrolidine as acetylcholinesterase inhibitors. J Enzyme Inhib Med Chem 2020;35:31-41. [PMID: 31645149 DOI: 10.1080/14756366.2019.1680659] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
Genc Bilgicli H, Taslimi P, Akyuz B, Tuzun B, Gulcin İ. Synthesis, characterization, biological evaluation, and molecular docking studies of some piperonyl‐based 4‐thiazolidinone derivatives. Arch Pharm Chem Life Sci 2019;353:1900304. [DOI: 10.1002/ardp.201900304] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 17 |
Fu Z, Jin Q, Qu Y, Guan L. Chalcone derivatives bearing chromen or benzo[f]chromen moieties: Design, synthesis, and evaluations of anti-inflammatory, analgesic, selective COX-2 inhibitory activities. Bioorganic & Medicinal Chemistry Letters 2019;29:1909-12. [DOI: 10.1016/j.bmcl.2019.05.051] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 18 |
Mohamed AH, Shaker RM. An Efficient Method for the Synthesis ofN‐uracil‐4‐oxo‐thiazolidines without Catalyst. J Heterocyclic Chem 2019;56:2099-2104. [DOI: 10.1002/jhet.3589] [Reference Citation Analysis]
|
| 19 |
Arshad F, Khan MF, Akhtar W, Alam MM, Nainwal LM, Kaushik SK, Akhter M, Parvez S, Hasan SM, Shaquiquzzaman M. Revealing quinquennial anticancer journey of morpholine: A SAR based review. Eur J Med Chem 2019;167:324-56. [PMID: 30776694 DOI: 10.1016/j.ejmech.2019.02.015] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 20 |
Berwaldt GA, Gouvêa DP, da Silva DS, das Neves AM, Soares MSP, Azambuja JH, Siqueira GM, Spanevello RM, Cunico W. Synthesis and biological evaluation of benzothiazin-4-ones: a possible new class of acetylcholinesterase inhibitors. J Enzyme Inhib Med Chem 2019;34:197-203. [PMID: 30482059 DOI: 10.1080/14756366.2018.1543286] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 21 |
Neves AM, Campos JC, Gouvêa DP, Berwaldt GA, Goulart TB, Avila CT, Machado P, Zimmer GC, Cunico W. Synthesis of Novel Thiazolidin‐4‐ones and Thiazinan‐4‐ones Analogous to Rosiglitazone. J Heterocyclic Chem 2019;56:251-9. [DOI: 10.1002/jhet.3402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Zehetmeyr FK, da Silva MAMP, Pereira KM, Berne MEA, Cunico W, Campos JC Júnior, Gouvea DP, da Silva Nascente P, de Oliveira Hübner S, Siqueira GM. Ovicidal in vitro activity of 2-aryl-3-(2-morpholinoethyl)thiazolidin-4-ones and 2-aryl-3-(3-morpholinopropyl)thiazolidin-4-ones against Fasciola hepatica (Linnaeus, 1758). Exp Parasitol 2018;192:60-4. [PMID: 30040962 DOI: 10.1016/j.exppara.2018.07.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Kaboudin B, Abbasi Shiran J. Novel one-pot four-component condensation cyclization reactions for the synthesis of thiazolidine-4-one and 3 H -thiazoles. Journal of Sulfur Chemistry 2018;39:633-45. [DOI: 10.1080/17415993.2018.1497168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 24 |
Hwu JR, Gupta NK, Tsay SC, Huang WC, Albulescu IC, Kovacikova K, van Hemert MJ. Bis(benzofuran-thiazolidinone)s and bis(benzofuran-thiazinanone)s as inhibiting agents for chikungunya virus. Antiviral Res 2017;146:96-101. [PMID: 28830714 DOI: 10.1016/j.antiviral.2017.08.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 25 |
Elzahhar PA, Elkazaz S, Soliman R, El-tombary AA, Shaltout HA, El-ashmawy IM, Abdel Wahab AE, El-hawash SA. Design and synthesis of some new 2,3′-bipyridine-5-carbonitriles as potential anti-inflammatory/antimicrobial agents. Future Medicinal Chemistry 2017;9:1413-50. [DOI: 10.4155/fmc-2017-0071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 26 |
Guan L, Xia Y, Jin Q, Liu B, Wang S. Synthesis, potential anti-inflammatory and analgesic activities study of ( S )- N -substituted-1-phenyl-3,4-dihydroisoquinoline-2(1 H )-carboxamides. Bioorganic & Medicinal Chemistry Letters 2017;27:3378-81. [DOI: 10.1016/j.bmcl.2017.06.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 27 |
Subhedar DD, Shaikh MH, Shingate BB, Nawale L, Sarkar D, Khedkar VM. Novel tetrazoloquinoline–thiazolidinone conjugates as possible antitubercular agents: synthesis and molecular docking. Med Chem Commun 2016;7:1832-48. [DOI: 10.1039/c6md00278a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
